Haematology Flashcards

1
Q

What type of tyrosine kinase receptor is mainly implicated in myeloid cells?

A

JAK2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the growth factors for RBCs and platelets respectively?

A

Erythropoietin and Thrombopoietin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does STAT stand for and where is it placed in the cascade of cell proliferation?

A

Signal transducer and activation of transcription.

When the growth factor binds to JAK2, this leads to phosphorylation and activation of STAT, which leads to trasncription of genes involved in cell porliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which cell types are overproduced in PCV? What are the EPO levels in PCV?

A

There is overproduction of RBCs. There often is also increased production of platelets and granulocytic cells.

EPO levels are suppressed, as RBC produciton is independant of levels that usually control erythropoiesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does PCV present?

A
  • Often incidental finding on routine blood test
  • Symptoms of hyperviscosity/↑platelets:
    • Headache/light headedness
    • Stroke/TIAs (+ thrombosis all over)
    • Visual disturbances (+retinal vein engorgement)
    • Fatigue
    • Dyspnoea
  • Symptoms of ↑histamine (as there are ↑mast cells/basophils)
    • Aquagenic pruritus
    • Peptic ulceration
  • Splenomegaly
  • Plethora
  • Gout (↑ cell turnover ↑uric acid production)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What investigations are indicated in a patient with suspected PCV?

A
  • FBC (↑Hb, ↑Hct, ↑Platelets, noramal or ↑ WCC)
  • Isotype dilution indicating ↑plasma volume
  • BM aspirate ↑cellularity (mainly erythrocytes, megakaryocytes) MATURE cells
  • EPO: low
  • JAK2 V617F mutation (DAGNOSTIC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name causes for primary and secondary erythrocytosis.

A

Erythrocytosis is the isolated incrased in RBCs (thereby differing from PCV).

Primary Erythrocytosis is due to a mutation in the EPO receptor. Thoght to be on Exon 12.

Secondary erythrocytosis due to chronic hypoxia (e.g. hgih latitude living, chronic lung disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the principles of treatment for PCV?

A

Reduce Viscosity:

  • Venesection
  • Cytoreductive therapy (hydroxycarbamide)

Reduce thrombosis risk:

  • Aspirin
  • Keep platelets <400 x10^9
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the principles of treatment for primary erythrocytosis

A

Venesection only.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is essential thrombocythaemia (ET)?

A

Chronic myeloproliferative disease involving the megakaryocyte lineage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does ET present?

A
  • 50% incidental finding on routine blood
  • Thrombosis:
    • Arterial: CVA, gangrene, TIAs
    • Venous: DVTs, PEs
  • Bleeding (mucous membranes, cutaneous)
  • Headaches, dizziness, visual disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the diagnostic criteria for ET?

A
  • >600 x10^9 consistently
  • Abnormal megakaryocytes and clustering
  • Absence of evidence for reactive thrombocytosis (i.e. no infection/inflammation, no neoplasia, no splenectomy)
  • Symptoms + JAK2 V617F mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the apporaches to treating ET?

A
  • Aspirin
  • Cytoreductive therapy
    • Hydroxycarbamide
    • Anagrelide (specific platelet inhibition)
  • alpha-IFN in pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How doeshydroxacarbamide work?

A

It’s an antimetabolie, therefore also causes suppression of other cell types.

It is thought to be mildy leukaemogenic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is myelofibrosis?

A

It is a clonal myeloproliferative disease associated with reactive BM fibrosis and extramedullary haematopoiesis.

The “reactive” refers to the fact that it is due to cytokines produced by the abnormal haemotopoietic cell clones that lead to fibrosis.

Idiopathic myelofibrosis means the disease is of unkown origin, but it can also be secondary to PCV or ET.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do patients with myelofibrosis present?

A
  • 30% are incidental findings
  • Cytopenia (anaemia/thrombocytopaenia)
  • if secondary to ET/PCV: thrombocytosis/↑RBC
  • Splenomegaly (might be massive) (Budd-Chiari, i.e. hepatic vein thrombosis)
  • Hepatomegaly
17
Q

What are the haematoloical findings of myelofibrosis?

A

Blood film:

  • Leukoerythroblastic picture (immature leukocytes and nucleated RBCs in circulation)
  • Tear drop poikilocytes
  • Giant platelets/circulating megakaryocytes

Bone Marrow:

  • Dry tap
  • Trephine Holes” (↑reticulin/collagen fibrosis)
  • Prominent megakaryocyte hyperplasia with clustering abnormlaities

Extramedullary haematopoiesis in liver and spleen

18
Q

How would you treat myelofibrosis?

A

Often we just aim to treat the symptoms:

  • Anaemia: transfusions
  • Platelet transfusions
  • Splenectomy
  • Cytoreductive therapy
  • BM transplant
19
Q

What is the prognosis for myelofibrosis? What are 3 negative predictive factors?

A

3-5 years medain survival.

  1. Severa anaemia
  2. Thrombocytopaenia <100 x10^9
  3. Massive splenomegaly

are negative predictive factors.

20
Q
A